Found: 8
Select item for more details and to access through your institution.
A prospective evaluation of the utility of 2-deoxy-2-[(18) F]fluoro-D-glucose positron emission tomography and computed tomography in staging locally advanced gastric cancer.
- Published in:
- 2012
- By:
- Publication type:
- journal article
18F-Fluciclovine (18F-FACBC) PET imaging of recurrent brain tumors.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2020, v. 47, n. 6, p. 1353, doi. 10.1007/s00259-019-04433-1
- By:
- Publication type:
- Article
Correction to: <sup>18</sup>F-Fluciclovine (<sup>18</sup>F-FACBC) PET imaging of recurrent brain tumors.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
NEW PROGNOSTIC SCORE INCORPORATING MTV PREDICTS TREATMENT FAILURE IN ADVANCED HODGKIN LYMPHOMA.
- Published in:
- Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.73_2879
- By:
- Publication type:
- Article
CALGB 50801 (ALLIANCE): PET ADAPTED THERAPY IN BULKY STAGE I/II CLASSIC HODGKIN LYMPHOMA (CHL)
- Published in:
- Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.72_2879
- By:
- Publication type:
- Article
PREDICTIVE VALUE OF QUANTITATIVE <sup>18</sup>F‐FDG‐PET‐CT RADIOMICS ANALYSIS IN 174 PATIENTS WITH RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA.
- Published in:
- Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.21_2879
- By:
- Publication type:
- Article
BASELINE METABOLIC TUMOR VOLUME IS AN INDEPENDENT PROGNOSTIC FACTOR FOR RELAPSED AND REFRACTORY HODGKIN LYMPHOMA PATIENTS RECEIVING PET-ADAPTED SALVAGE THERAPY WITH BRENTUXIMAB VEDOTIN AND AUGMENTED ICE.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 36, doi. 10.1002/hon.2437_17
- By:
- Publication type:
- Article
KRAS mutation effects on the 2-[18F]FDG PET uptake of colorectal adenocarcinoma metastases in the liver.
- Published in:
- EJNMMI Research, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1186/s13550-020-00707-0
- By:
- Publication type:
- Article